BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 18194706)

  • 1. "Male lumpectomy": focal therapy for prostate cancer using cryoablation.
    Onik G; Vaughan D; Lotenfoe R; Dineen M; Brady J
    Urology; 2007 Dec; 70(6 Suppl):16-21. PubMed ID: 18194706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The "male lumpectomy": focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up.
    Onik G; Vaughan D; Lotenfoe R; Dineen M; Brady J
    Urol Oncol; 2008; 26(5):500-5. PubMed ID: 18774463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for a "male lumpectomy," a prostate cancer targeted approach using cryoablation: results in 21 patients with at least 2 years of follow-up.
    Onik G
    Cardiovasc Intervent Radiol; 2008; 31(1):98-106. PubMed ID: 17593431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryosurgical ablation of the prostate: high risk patient outcomes.
    Prepelica KL; Okeke Z; Murphy A; Katz AE
    Cancer; 2005 Apr; 103(8):1625-30. PubMed ID: 15747374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results.
    Ellis DS; Manny TB; Rewcastle JC
    Urology; 2007 Dec; 70(6 Suppl):9-15. PubMed ID: 18194712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer.
    Lambert EH; Bolte K; Masson P; Katz AE
    Urology; 2007 Jun; 69(6):1117-20. PubMed ID: 17572198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
    Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
    J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure.
    Eisenberg ML; Shinohara K
    Urology; 2008 Dec; 72(6):1315-8. PubMed ID: 18597824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage prostate cryoablation: initial results from the cryo on-line data registry.
    Pisters LL; Rewcastle JC; Donnelly BJ; Lugnani FM; Katz AE; Jones JS
    J Urol; 2008 Aug; 180(2):559-63; discussion 563-4. PubMed ID: 18554664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience.
    Siddiqui SA; Mynderse LA; Zincke H; Hoffmann NE; Lobo JR; Wilson TM; Kawashima A; Davis BJ; Blute ML
    Urology; 2007 Jul; 70(1):80-5. PubMed ID: 17656213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation.
    Ellis DS; Manny TB; Rewcastle JC
    Urology; 2007 Feb; 69(2):306-10. PubMed ID: 17320669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experience.
    Barzell WE; Melamed MR
    Urology; 2007 Dec; 70(6 Suppl):27-35. PubMed ID: 18194708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients.
    Ismail M; Ahmed S; Kastner C; Davies J
    BJU Int; 2007 Oct; 100(4):760-4. PubMed ID: 17662081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy.
    Ward JF; Nakanishi H; Pisters L; Babaian RJ; Troncoso P
    BJU Int; 2009 Aug; 104(4):490-7. PubMed ID: 19220260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
    Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA
    Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
    Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y
    Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology.
    Polascik TJ; Nosnik I; Mayes JM; Mouraviev V
    Urology; 2007 Jul; 70(1):117-21. PubMed ID: 17656220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?
    Tareen B; Godoy G; Sankin A; Temkin S; Lepor H; Taneja SS
    BJU Int; 2009 Jul; 104(2):195-9. PubMed ID: 19191784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.